Long Non-coding RNA SNHG1 Stimulates Ovarian Cancer Progression by Modulating Expression of MiR-454 and ZEB1

Overview

Journal Mol Oncol

Specialties Molecular Biology
Oncology

Date 2021 Feb 28

PMID 33641229

Citations 11

Authors

Yinying Wu

Bo Zhu

Yanli Yan

Shuheng Bai

Haojing Kang

Jiangzhou Zhang

Wen Ma

Ying Gao

Beina Hui

Rong Li

Xiaozhi Zhang

Juan Ren

Affiliations

Soon will be listed here.

Abstract

Ovarian cancer (OC) is highly prevalent and is associated with high mortality rates due to metastasis and relapse. In this study, we assessed the role of long non-coding RNA (lncRNA) small nucleolar RNA host gene 1 (SNHG1) in OC to gain further insight into mechanisms that contribute to its aggressiveness. We analyzed the correlation between SNHG1, miR-454 and zinc finger E-box-binding homeobox 1 (ZEB1) using a dual-luciferase reporter assay. Alterations in cell metastasis and invasiveness were observed using wound-healing and Transwell invasion assays, respectively. Tumor xenografts allowed us to monitor liver metastasis of mice injected with A2780 cells. We found that SNHG1 is overexpressed in OC. Downregulation of SNHG1 promoted miR-454 expression and reduced ZEB1 levels. In addition, knockdown of SNHG1, also reduced the aggressiveness of A2780 and SK-OV3 cells. Furthermore, SNHG1 downregulation by siRNA hindered cell migration and invasion; however, this effect was reversed by co-transfection of miR-454 into A2780 and SK-OV3 cells. Moreover, SNHG1 increased ZEB1 expression by downregulating miR-454 and activated Akt signaling, thereby promoting epithelial-mesenchymal transition and enhancing the invasiveness of OC cells. Tumor xenograft analyses confirmed that SNHG1 affects OC proliferation and metastasis in vivo. In summary, our data demonstrate that SNHG1 plays crucial roles in tumor progression and may be a useful maker for OC prognosis.

Citing Articles

ZEB1 promotes the immune escape of ovarian cancer through the MCSF-CCL18 axis.

Jin Y, Li G, Xu Q, Wang X Cancer Cell Int. 2025; 25(1):95.

PMID: 40089803 DOI: 10.1186/s12935-025-03724-y.

Competing endogenous RNA networks in ovarian cancer: from bench to bedside.

Derogar R, Nejadi Orang F, Shadbad M EXCLI J. 2025; 24:86-112.

PMID: 39967908 PMC: 11830916. DOI: 10.17179/excli2024-7827.

Long Non-Coding RNAs in Ovarian Cancer: Mechanistic Insights and Clinical Applications.

Basu S, Nadhan R, Dhanasekaran D Cancers (Basel). 2025; 17(3).

PMID: 39941838 PMC: 11815776. DOI: 10.3390/cancers17030472.

Long non‑coding RNA SNHG1 promotes autophagy in vascular smooth muscle cells induced by facilitating CLEC7A.

Deng H, Teng W, Zhou S, Ye Z, Dong Z, Hu R Mol Med Rep. 2024; 31(1).

PMID: 39513586 PMC: 11564905. DOI: 10.3892/mmr.2024.13385.

Single-cell sequencing combined with spatial transcriptomics reveals that the IRF7 gene in M1 macrophages inhibits the occurrence of pancreatic cancer by regulating lipid metabolism-related mechanisms.

Zhan T, Zou Y, Han Z, Tian X, Chen M, Liu J Clin Transl Med. 2024; 14(8):e1799.

PMID: 39118300 PMC: 11310283. DOI: 10.1002/ctm2.1799.

References

Vergara D, Merlot B, Lucot J, Collinet P, Vinatier D, Fournier I . Epithelial-mesenchymal transition in ovarian cancer. Cancer Lett. 2009; 291(1):59-66. DOI: 10.1016/j.canlet.2009.09.017. View

Bao X, Ren T, Huang Y, Sun K, Wang S, Liu K . Knockdown of long non-coding RNA HOTAIR increases miR-454-3p by targeting Stat3 and Atg12 to inhibit chondrosarcoma growth. Cell Death Dis. 2017; 8(2):e2605. PMC: 5386479. DOI: 10.1038/cddis.2017.31. View

Mitra R, Chen X, Greenawalt E, Maulik U, Jiang W, Zhao Z . Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition. Nat Commun. 2017; 8(1):1604. PMC: 5693921. DOI: 10.1038/s41467-017-01781-0. View

Duran G, Wang Y, Moisan F, Francisco E, Sikic B . Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition. Br J Cancer. 2017; 116(10):1318-1328. PMC: 5482726. DOI: 10.1038/bjc.2017.102. View

Gregory P, Bert A, Paterson E, Barry S, Tsykin A, Farshid G . The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008; 10(5):593-601. DOI: 10.1038/ncb1722. View

Lan X, Liu X . LncRNA SNHG1 functions as a ceRNA to antagonize the effect of miR-145a-5p on the down-regulation of NUAK1 in nasopharyngeal carcinoma cell. J Cell Mol Med. 2018; 23(4):2351-2361. PMC: 6434074. DOI: 10.1111/jcmm.13497. View

Cui Y, Zhang F, Zhu C, Geng L, Tian T, Liu H . Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway. Oncotarget. 2017; 8(11):17785-17794. PMC: 5392286. DOI: 10.18632/oncotarget.14854. View

Zhang L, Nadeem L, Connor K, Xu G . Mechanisms and Therapeutic Targets of microRNA-associated Chemoresistance in Epithelial Ovarian Cancer. Curr Cancer Drug Targets. 2016; 16(5):429-41. DOI: 10.2174/1568009616666160404121105. View

Nicoloso M, Spizzo R, Shimizu M, Rossi S, Calin G . MicroRNAs--the micro steering wheel of tumour metastases. Nat Rev Cancer. 2009; 9(4):293-302. DOI: 10.1038/nrc2619. View

10.

Li L, Gu M, You B, Shi S, Shan Y, Bao L . Long non-coding RNA ROR promotes proliferation, migration and chemoresistance of nasopharyngeal carcinoma. Cancer Sci. 2016; 107(9):1215-22. PMC: 5021023. DOI: 10.1111/cas.12989. View

11.

Cao Z, Li J, Yao L, Huang Y, Liu Y, Hu X . High expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancer. Oncotarget. 2016; 7(40):64900-64909. PMC: 5323124. DOI: 10.18632/oncotarget.11764. View

12.

Huang K, Geng J, Wang J . Long non-coding RNA RP11-552M11.4 promotes cells proliferation, migration and invasion by targeting BRCA2 in ovarian cancer. Cancer Sci. 2018; 109(5):1428-1446. PMC: 5980309. DOI: 10.1111/cas.13552. View

13.

Koutsaki M, Spandidos D, Zaravinos A . Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics. Cancer Lett. 2014; 351(2):173-81. DOI: 10.1016/j.canlet.2014.05.022. View

14.

Fan Y, Shi C, Li T, Kuang T . microRNA-454 shows anti-angiogenic and anti-metastatic activity in pancreatic ductal adenocarcinoma by targeting LRP6. Am J Cancer Res. 2017; 7(1):139-147. PMC: 5250688. View

15.

Li J, Zhang Z, Xiong L, Guo C, Jiang T, Zeng L . SNHG1 lncRNA negatively regulates miR-199a-3p to enhance CDK7 expression and promote cell proliferation in prostate cancer. Biochem Biophys Res Commun. 2017; 487(1):146-152. DOI: 10.1016/j.bbrc.2017.03.169. View

16.

Guo H, Ingolia N, Weissman J, Bartel D . Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010; 466(7308):835-40. PMC: 2990499. DOI: 10.1038/nature09267. View

17.

Li Q, Liu J, Meng X, Pang R, Li J . MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer. J Biol Res (Thessalon). 2017; 24:10. PMC: 5541748. DOI: 10.1186/s40709-017-0067-x. View

18.

Sun L, Wang Q, Gao X, Shi D, Mi S, Han Q . MicroRNA-454 functions as an oncogene by regulating PTEN in uveal melanoma. FEBS Lett. 2015; 589(19 Pt B):2791-6. DOI: 10.1016/j.febslet.2015.08.007. View

19.

Van Tubergen E, Banerjee R, Liu M, Vander Broek R, Light E, Kuo S . Inactivation or loss of TTP promotes invasion in head and neck cancer via transcript stabilization and secretion of MMP9, MMP2, and IL-6. Clin Cancer Res. 2013; 19(5):1169-79. PMC: 3594656. DOI: 10.1158/1078-0432.CCR-12-2927. View

20.

Guo Y, Lang X, Lu Z, Wang J, Li T, Liao Y . MiR-10b Directly Targets ZEB1 and PIK3CA to Curb Adenomyotic Epithelial Cell Invasiveness via Upregulation of E-Cadherin and Inhibition of Akt Phosphorylation. Cell Physiol Biochem. 2015; 35(6):2169-80. DOI: 10.1159/000374022. View